{"nct_id":"NCT04789577","title":"A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2021-03-16","start_date_type":"ACTUAL","primary_completion_date":"2022-09-12","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}